A Study to Evaluate the Safety and Pharmacokinetics of AD-116 and AD-1161 in Healthy Adult Male Subjects

Trial statusRecruiting

Trial phasePhase 1

Trial typeInterventional

Biological sexMale

Age19+

SponsorAddpharma Inc.

About this trial

A Study to Evaluate the Safety and Pharmacokinetics of AD-116 and AD-1161 Under Fed Conditions in Healthy Adult Male Subjects

Body weight equal to or greater than 50kg and Body mass index (BMI) between 18.0 kg/m2 and 30.0 kg/m2 at the time of screening visit

The Age equal to or greater than 19 in healthy adult male volunteers at the time of screening visit

Participation in another clinical study with an investigational drug within the 6 months from scheduled first administration

Other exclusions applied

44 Participants

are divided into 2 treatment groups

Addpharma Inc.

Lead sponsor